Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2006 1
2007 1
2008 2
2009 2
2016 1
2017 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

8 results
Results by year
Filters applied: . Clear all
Page 1
Efficacy and safety of idelalisib in patients with relapsed, rituximab- and alkylating agent-refractory follicular lymphoma: a subgroup analysis of a phase 2 study.
Salles G, Schuster SJ, de Vos S, Wagner-Johnston ND, Viardot A, Blum KA, Flowers CR, Jurczak WJ, Flinn IW, Kahl BS, Martin P, Kim Y, Shreay S, Will M, Sorensen B, Breuleux M, Zinzani PL, Gopal AK. Salles G, et al. Among authors: breuleux m. Haematologica. 2017 Apr;102(4):e156-e159. doi: 10.3324/haematol.2016.151738. Epub 2016 Dec 15. Haematologica. 2017. PMID: 27979923 Free PMC article. Clinical Trial. No abstract available.
Role of heregulin in human cancer.
Breuleux M. Breuleux M. Cell Mol Life Sci. 2007 Sep;64(18):2358-77. doi: 10.1007/s00018-007-7120-0. Cell Mol Life Sci. 2007. PMID: 17530167 Review.
Optimal targeting of the mTORC1 kinase in human cancer.
Lane HA, Breuleux M. Lane HA, et al. Among authors: breuleux m. Curr Opin Cell Biol. 2009 Apr;21(2):219-29. doi: 10.1016/ Epub 2009 Feb 21. Curr Opin Cell Biol. 2009. PMID: 19233631 Review.
Uncertain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53.
Pirnia F, Breuleux M, Schneider E, Hochmeister M, Bates SE, Marti A, Hotz MA, Betticher DC, Borner MM. Pirnia F, et al. Among authors: breuleux m. J Natl Cancer Inst. 2000 Sep 20;92(18):1535-6. doi: 10.1093/jnci/92.18.1535. J Natl Cancer Inst. 2000. PMID: 10995814 Free article. No abstract available.